Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 30, 2019

SELL
$59.06 - $72.15 $65,733 - $80,302
-1,113 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$62.09 - $86.14 $29,803 - $41,347
480 Added 75.83%
1,113 $71,000
Q1 2019

May 06, 2019

SELL
$52.92 - $81.17 $4,921 - $7,548
-93 Reduced 12.81%
633 $51,000
Q4 2018

Feb 01, 2019

BUY
$43.37 - $59.54 $31,486 - $43,226
726 New
726 $39,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Essex Savings Bank Portfolio

Follow Essex Savings Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Essex Savings Bank with notifications on news.